Biological response modifiers: the new immunotherapy
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 1989-04, Vol.49 (7), p.1621-1639 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1639 |
---|---|
container_issue | 7 |
container_start_page | 1621 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 49 |
creator | FOON, K. A |
description | |
format | Article |
fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_2466558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2466558</sourcerecordid><originalsourceid>FETCH-LOGICAL-p167t-e7cf3d13745527b8ac28f59eb751de55be21356634e93b9f203bca1fc20180263</originalsourceid><addsrcrecordid>eNo9j01LAzEYhIModa3-BGEPXhfy9SZZb1q0CgUvei5J9o1G9iMkLdJ_74KLp-FhhmHmjFQMhGm0lHBOKkqpaUBqfkmuSvmeERiFFVlxqRSAqYh8jFM_fUZv-zpjSdNYsB6mLoaIudzXhy-sR_yp4zAcx2mmbNPpmlwE2xe8WXRNPp6f3jcvze5t-7p52DWJKX1oUPsgOia0BODaGeu5CdCi08A6BHDImQClhMRWuDZwKpy3LHhOmaFciTW5_etNRzdgt085Djaf9sv62b9bfFvmAyHb0cfyH9O8VRK4-AUPJ03S</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Biological response modifiers: the new immunotherapy</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><creator>FOON, K. A</creator><creatorcontrib>FOON, K. A</creatorcontrib><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 2466558</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Colony-Stimulating Factors - therapeutic use ; Humans ; Immunotherapy ; Immunotoxins - therapeutic use ; Interferons - therapeutic use ; Interleukin-2 - therapeutic use ; Killer Cells, Natural - immunology ; Neoplasms - therapy ; Tumor Necrosis Factor-alpha - therapeutic use</subject><ispartof>Cancer research (Chicago, Ill.), 1989-04, Vol.49 (7), p.1621-1639</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7296452$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2466558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FOON, K. A</creatorcontrib><title>Biological response modifiers: the new immunotherapy</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Colony-Stimulating Factors - therapeutic use</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Immunotoxins - therapeutic use</subject><subject>Interferons - therapeutic use</subject><subject>Interleukin-2 - therapeutic use</subject><subject>Killer Cells, Natural - immunology</subject><subject>Neoplasms - therapy</subject><subject>Tumor Necrosis Factor-alpha - therapeutic use</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j01LAzEYhIModa3-BGEPXhfy9SZZb1q0CgUvei5J9o1G9iMkLdJ_74KLp-FhhmHmjFQMhGm0lHBOKkqpaUBqfkmuSvmeERiFFVlxqRSAqYh8jFM_fUZv-zpjSdNYsB6mLoaIudzXhy-sR_yp4zAcx2mmbNPpmlwE2xe8WXRNPp6f3jcvze5t-7p52DWJKX1oUPsgOia0BODaGeu5CdCi08A6BHDImQClhMRWuDZwKpy3LHhOmaFciTW5_etNRzdgt085Djaf9sv62b9bfFvmAyHb0cfyH9O8VRK4-AUPJ03S</recordid><startdate>19890401</startdate><enddate>19890401</enddate><creator>FOON, K. A</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19890401</creationdate><title>Biological response modifiers: the new immunotherapy</title><author>FOON, K. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p167t-e7cf3d13745527b8ac28f59eb751de55be21356634e93b9f203bca1fc20180263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Colony-Stimulating Factors - therapeutic use</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Immunotoxins - therapeutic use</topic><topic>Interferons - therapeutic use</topic><topic>Interleukin-2 - therapeutic use</topic><topic>Killer Cells, Natural - immunology</topic><topic>Neoplasms - therapy</topic><topic>Tumor Necrosis Factor-alpha - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FOON, K. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FOON, K. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biological response modifiers: the new immunotherapy</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1989-04-01</date><risdate>1989</risdate><volume>49</volume><issue>7</issue><spage>1621</spage><epage>1639</epage><pages>1621-1639</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>2466558</pmid><tpages>19</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1989-04, Vol.49 (7), p.1621-1639 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_pubmed_primary_2466558 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research |
subjects | Antibodies, Monoclonal - therapeutic use Colony-Stimulating Factors - therapeutic use Humans Immunotherapy Immunotoxins - therapeutic use Interferons - therapeutic use Interleukin-2 - therapeutic use Killer Cells, Natural - immunology Neoplasms - therapy Tumor Necrosis Factor-alpha - therapeutic use |
title | Biological response modifiers: the new immunotherapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A52%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biological%20response%20modifiers:%20the%20new%20immunotherapy&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=FOON,%20K.%20A&rft.date=1989-04-01&rft.volume=49&rft.issue=7&rft.spage=1621&rft.epage=1639&rft.pages=1621-1639&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E2466558%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2466558&rfr_iscdi=true |